SB 70 · 2023-24
Bars health plans from dropping off-label drug coverage
Official subject Prescription drug coverage.
Didn't pass Passed Senate, stopped in Assembly · Held in committee
Plain-language summary
Health plans and insurers cannot limit or exclude coverage of a drug, dose, or dosage form prescribed off-label if it was already covered for a chronic condition or cancer. This applies even if the drug is not on the plan's formulary. Plans cannot add new cost sharing for a drug they previously approved.
Official summary · Legislative Counsel's Digest
Describes the final version (Amended Assembly, June 29, 2023).
Read the official summary (4 paragraphs)
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law generally authorizes a health care service plan or health insurer to use utilization review, under which a licensed physician or a licensed health care professional who is competent to evaluate specific clinical issues may approve, modify, delay, or deny requests for health care services based on medical necessity. Existing law prohibits a health care service plan contract that covers prescription drug benefits or a specified health insurance policy from limiting or excluding coverage for a drug on the basis that the drug is prescribed for a use that is different from the use for which it was approved by the federal Food and Drug Administration if specified conditions are met. Existing law also prohibits a health care service plan that covers prescription drug benefits from limiting or excluding coverage for a drug that was previously approved for coverage if an enrollee continues to be prescribed that drug, as specified.
This bill would additionally prohibit limiting or excluding coverage of a drug, dose of a drug, or dosage form of a drug that is prescribed for off-label use if the drug has been previously covered for a chronic condition or cancer, as specified, regardless of whether or not the drug, dose, or dosage form is on the plan’s or insurer’s formulary. The bill would prohibit a health care service plan contract or health insurance policy from requiring additional cost sharing not already imposed for a drug that was previously approved for coverage. Because a willful violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Official title
An act to amend Sections 1367.21 and 1367.22 of the Health and Safety Code, and to amend Section 10123.195 of, and to add Section 10123.190 to, the Insurance Code, relating to health care coverage.
Timeline
- Jan. 9, 2023 Introduced
- May 24, 2023 Passed Senate 31 yes, 9 no
- Sept. 1, 2023 Stopped in the Assembly Held in committee
Full official history (19 actions)
- Jan. 9, 2023 Introduced: Introduced. Read first time. To Com. on RLS. for assignment. To print.
- Jan. 10, 2023 From printer. May be acted upon on or after February 9.
- Jan. 18, 2023 Referred to Com. on HEALTH.
- March 8, 2023 From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
- March 28, 2023 Set for hearing April 12.
- April 17, 2023 From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 10. Noes 1. Page 710.) (April 12).
- April 18, 2023 Read second time and amended. Re-referred to Com. on APPR.
- April 21, 2023 Set for hearing May 1.
- May 1, 2023 May 1 hearing: Placed on APPR suspense file.
- May 12, 2023 Set for hearing May 18.
- May 18, 2023 From committee: Do pass. (Ayes 5. Noes 2. Page 1159.) (May 18).
- May 18, 2023 Read second time. Ordered to third reading.
- May 24, 2023 Passed Senate: Read third time. Passed. (Ayes 31. Noes 9. Page 1274.) Ordered to the Assembly.
- May 25, 2023 In Assembly. Read first time. Held at Desk.
- June 1, 2023 Referred to Com. on HEALTH.
- June 28, 2023 From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 12. Noes 3.) (June 27).
- June 29, 2023 Read second time and amended. Re-referred to Com. on APPR.
- Aug. 16, 2023 August 16 set for first hearing. Placed on suspense file.
- Sept. 1, 2023 September 1 hearing: Held in committee and under submission.